Outcome of double-headed pterygium surgery

Cornea

Volumn 22, Issue 6, 2003, Pages 501-503

  Avisar, Rahamim ^a   Snir, Moshe ^b   Weinberger, Dov ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Double head pterygia; Mitomycin C

Indexed keywords

CHLORAMPHENICOL DERIVATIVE; DEXAMETHASONE SODIUM PHOSPHATE; DEXAMYCINE; DICLOFENAC; MITOMYCIN C; NEOMYCIN; PHENIMIXINE; POLYMYXIN B;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EYE SURGERY; FEMALE; HUMAN; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PTERYGIUM; PYOGENIC GRANULOMA; RECURRENCE RISK; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; GRANULOMA, PYOGENIC; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS; OPHTHALMOLOGIC SURGICAL PROCEDURES; PROSPECTIVE STUDIES; PTERYGIUM; RECURRENCE; REOPERATION; SCLERA; TREATMENT OUTCOME;

EID: 0042845714     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200308000-00002     Document Type: Article

References (20)

1. Solomon A, Pires RTF, Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001;108:449-460.
2. Kintworth GK. Chronic actinic keratopathy: a condition associated with conjunctival elastosis (pinguecula) and typified by characteristic extracellular concretion. Am J Pathol. 1972;67:372.
3. Joselson GA, Muller P. Incidence of pterygium recurrence in patients treated with thio-tepa. Am J Ophthalmol. 1966;61:891-892.
4. Crooke ST, Brander WT. Mitomycin C: a review. Cancer Treat Rev. 1976;3:121-139.
5. Sugar A. Who should receive mitomycin-C after pterygium surgery? Ophthalmology. 1992;99:1645-1646.
6. Kunitomo N, Mori S. Studies on the pterygia; part IV. Acta Ophthalmol Jpn. 1963;67:601-607.
7. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment of pterygium. Ophthalmology. 1988;95:813-821.
8. Mastropasqua L, Carpineto P, Ciancaglini M, et al. Effectiveness of intraoperative mitomycin C in the treatment of recurrent pterygium. Ophthalmologica. 1994;208:247-249.
9. Rubinfeld RS, Stein RM. Topical mitomycin-C for pterygia: is a single application appropriate? Ophthalmic Surg Lasers. 1997;28:662-669.
10. Avisar R, Dan DG, Nisin L, et al. Intraoperative mitomycin C 0.02% for pterygium-effect of duration of application on recurrence rate. Cornea. 2003;22:102-104.
11. Caliskan S, Orhan M, Irkec M. Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium. Ophthalmic Surg Lasers. 1996;27:600-604.
12. Frucht-Pery J, Ilsar M, Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea. 1994;13:411-413.
13. Mastropasqua L, Carpineto P, Ciancaglini M, et al. Long-term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol. 1996;80:288-291.
14. Cheng HC, Tseng SH, Kao PL, et al. Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery. Cornea. 20001;20:24-29.
15. Fujitani A, Hayasak S, Shibuia Y, et al. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica. 1993;207:162-164.
16. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin C. Cornea. 1996;15:537-540.
17. Dunn JP, Seamone CD, Ostler HB, et al. Development of scleral ulceration and classification after pterygium excision and mitomycin therapy. Am J Ophthalmol. 1991;112:343-344.
18. Safianic B, Ben-Zion I, Garzozy HJ. Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol. 2002;86:357-358.
19. Rubinfeld RS, Pfister RR, Stein RM, et al. Ophthalmology. 1992;99:1647-1654.
20. Guidera AC, Luchs JI, Udell IS. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology. 2001;108:936-944.